INHALATION OF FENOTEROL (BEROTEC) BY ASTHMATIC CHILDREN: A CLINICAL COMPARISON WITH SALBUTAMOL, ORCIPRENALINE AND ISOPRENALINE
- 1 September 1976
- journal article
- clinical trial
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (12) , 439-445
- https://doi.org/10.5694/j.1326-5377.1976.tb130323.x
Abstract
Fenoterol (Berotec) has been administered by inhalation, via a Bennett nebulizer, to symptom-free asthmatic children aged 6 to 14 years. The effects of treatment on the results of respiratory function tests, pulse rate and blood pressure were followed. The effects of fenoterol have been compared with those of placebo, salbutamol, orciprenaline and isoprenaline. Inhalation of 1 mg of fenoterol produced effective bronchodilatation, which was more than a placebo effect and was comparable with the responses achieved with other known effective bronchodilators given by inhalation. It produced only a minor increase in heart rate at this dose level.Keywords
This publication has 6 references indexed in Scilit:
- An examination of some β-adrenoreceptor stimulants for selectivity using the isolated trachea and atria of the guinea pigEuropean Journal of Pharmacology, 1972
- Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthmaArchives of Disease in Childhood, 1971
- A selective β-adrenoreceptor stimulant (Th1165a) related to orciprenalineEuropean Journal of Pharmacology, 1970
- Controlled Comparison of the Bronchodilator Effects of Three -Adrenergic Stimulant Drugs Administered by Inhalation to Patients with AsthmaBMJ, 1969
- Normal values of forced vital capacity (FVC), forced expiratory volume (FEV 1-0), and peak flow rate (PFR) in children.Archives of Disease in Childhood, 1968
- The Ventilatory Capacity of Normal ChildrenThorax, 1959